AAAAAA
Results:
1-7
|
Results: 7
Authors:
Yao, CP
Kunze, KL
Kharasch, ED
Wang, Y
Trager, WF
Ragueneau, I
Levy, RH
Citation: Cp. Yao et al., Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2, CLIN PHARM, 70(5), 2001, pp. 415-424
Authors:
Henne, KR
Kunze, KL
Zheng, YM
Christmas, P
Soberman, RJ
Rettie, AE
Citation: Kr. Henne et al., Covalent linkage of prosthetic heme to CYP4 family P450 enzymes, BIOCHEM, 40(43), 2001, pp. 12925-12931
Authors:
Gibbs, MA
Baillie, MT
Shen, DD
Kunze, KL
Thummel, KE
Citation: Ma. Gibbs et al., Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells, PHARM RES, 17(3), 2000, pp. 299-305
Authors:
Gibbs, MA
Kunze, KL
Howald, WN
Thummel, KE
Citation: Ma. Gibbs et al., Effect of inhibitor depletion on inhibitory potency: Tight binding inhibition of CYP3A by clotrimazole, DRUG META D, 27(5), 1999, pp. 596-599
Authors:
Gibbs, MA
Thummel, KE
Shen, DD
Kunze, KL
Citation: Ma. Gibbs et al., Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: Comparison of K-I values and impact of CYP3A5 expression, DRUG META D, 27(2), 1999, pp. 180-187
Authors:
Fisher, JM
Wrighton, SA
Watkins, PB
Schmiedlin-Ren, P
Calamia, JC
Shen, DD
Kunze, KL
Thummel, KE
Citation: Jm. Fisher et al., First-pass midazolam metabolism catalyzed by 1 alpha,25-dihydroxy vitamin D-3-modified Caco-2 cell monolayers, J PHARM EXP, 289(2), 1999, pp. 1134-1142
Authors:
Fisher, JM
Wrighton, SA
Calamia, JC
Shen, DD
Kunze, KL
Thummel, KE
Citation: Jm. Fisher et al., Midazolam metabolism by modified Caco-2 monolayers: Effects of extracellular protein binding, J PHARM EXP, 289(2), 1999, pp. 1143-1150
Risultati:
1-7
|